Modernas new vaccine manufacturing facility in Laval

Moderna’s new vaccine manufacturing facility in Laval

eAwaz Medicine

Prime Minister Justin Trudeau, took part in the ground-breaking of vaccine developer Moderna’s new state-of-the-art mRNA vaccine manufacturing facility in Laval, Quebec. When completed, this new facility will be able to produce up to 100 million made-in-Canada mRNA vaccine doses annually and will create hundreds of good jobs. The Prime Minister also took the opportunity to remind Canadians to keep up to date with their COVID-19 vaccinations, including getting booster shots when eligible to protect themselves and their loved ones.

The facility is expected to be completed in 2024 at the earliest. In addition to COVID-19 vaccines, it is expected to be able to produce vaccines for other respiratory diseases, such as influenza – pending their ongoing development by Moderna and approval by Health Canada.

During the pandemic, we worked hard to secure life-saving personal protective equipment, invest in our health care system, and ensure everyone eligible in Canada could get vaccinated. As we move forward, we will strengthen our biomanufacturing and life sciences sector to re-establish Canada’s domestic vaccine manufacturing capability, bring Canadian innovation to the front lines of tomorrow’s health solutions, and ensure we are better prepared for future health crises – all while growing the economy and creating good jobs.

“COVID-19 vaccines saved lives and got Canadians back to doing the things they love. Breaking ground on this vaccine manufacturing facility is an important milestone toward ensuring that Canadian workers and Canadian innovation play a key role in keeping our communities safe building an economy that works for all Canadians.” – – Justin Trudeau, Prime Minister of Canada

“Today’s ground-breaking for Moderna’s facility in Laval brings us one step closer to seeing the future of vaccines being developed right here in Canada. With talented workers, researchers and students, Laval will play a key role in global health and health innovation. Moderna’s presence in Canada will strengthen our national biomanufacturing ecosystem, positioning the entire sector to continue to grow and to create even more jobs right across the country.” – François-Philippe Champagne, Minister of Innovation, Science and Industry

“Staying up to date with vaccination continues to be one of the most effective ways to protect ourselves against serious illness, hospitalization, and death from COVID-19. By bolstering Canada’s domestic manufacturing capacity, we are strengthening domestic health security and pandemic preparedness through timely access to innovative, cutting-edge vaccines that help us save lives.” – Jean-Yves Duclos, Minister of Health